[
Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med 301, 682–686. 1979.
]Search in Google Scholar
[
Bravo EL. Diagnosis of pheochromocytoma. Reflections on a controversy. Hypertension 17, 742–744, 1991.
]Search in Google Scholar
[
Cascon A, Inglada-Perez L, Comino-Mendez I, de Cubas AA, Leton R, Mora J, Marazuela M, Galofre JC, Quesada-Charneco M, Robledo M. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr Relat Cancer 20, L1–L6, 2013.
]Search in Google Scholar
[
Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K; North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39, 775–783, 2010.
]Search in Google Scholar
[
Crout JR, Sjoerdsma A. Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest 43, 94–102, 1964.
]Search in Google Scholar
[
Duncan MW, Compton P, Lazarus L, Smythe GA. Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma. N Engl J Med 319, 136–142, 1988.
]Search in Google Scholar
[
Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11, 101–111, 2015.
]Search in Google Scholar
[
Eisenhofer G, Friberg P, Pacak K, Goldstein DS, Murphy DL, Tsigos C, Quyyumi AA, Brunner HG, Lenders JW. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci (Lond) 88, 533–542, 1995.
]Search in Google Scholar
[
Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83, 2175–2185, 1998.
]Search in Google Scholar
[
Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340, 1872–9187, 1999.
]Search in Google Scholar
[
Eisenhofer G, Walther M, Keiser HR, Lenders JW, Friberg P, Pacak K. Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. Braz J Med Biol Res 33, 1157–1169, 2000.
]Search in Google Scholar
[
Eisenhofer G. Free or total metanephrines for diagnosis of pheochromocytoma: what is the difference? Clin Chem 47, 988–989, 2001.
]Search in Google Scholar
[
Eisenhofer G. Biochemical diagnosis of pheochromocytoma-is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab 88, 550–552, 2003.
]Search in Google Scholar
[
Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88, 2656–2666, 2003.
]Search in Google Scholar
[
Else T, Greenberg S, Fishbein L. Hereditary paraganglioma-pheochromocytoma syndromes. 2008 May 21 [Updated 2018 Oct 4]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1548/.
]Search in Google Scholar
[
Erlic Z, Neumann HPH. Familial pheochromocytoma. Hormones (Athens) 8, 29–38, 2009.
]Search in Google Scholar
[
Faria JF, Goldman SM, Szejnfeld J, Melo H, Kater C, Kenney P, Huayllas MP, Demarchi G, Francisco VV, Andreoni C, Srougi M, Ortiz V, Abdalla N. Adrenal masses: Characterization with in vivo proton MR spectroscopy--initial experience. Radiology 245, 788–797, 2007.
]Search in Google Scholar
[
Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh QY. Clinical spectrum of pheochromocytoma. J Am Coll Surg 209, 727–732, 2009.
]Search in Google Scholar
[
King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M, Wesley R, Lodish M, Raygada M, Gimenez-Roqueplo AP, McCormack S, Eisenhofer G, Milosevic D, Kebebew E, Stratakis CA, Pacak K. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29, 4137–4142, 2011.
]Search in Google Scholar
[
Lenders JWM, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ. Determination of plasma metanephrines by liquid chromatography with electrochemical detection. Clin Chem 39, 97–103, 1993.
]Search in Google Scholar
[
Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC, Kloppenborg PW, Thien T, Eisenhofer G. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Int Med 123, 101–109, 1995.
]Search in Google Scholar
[
Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434, 2002.
]Search in Google Scholar
[
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366, 665–675, 2005.
]Search in Google Scholar
[
Maurea S, Cuocolo A, Reynolds JC, Neumann RD, Salvatore M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med 40, 365–371, 1996.
]Search in Google Scholar
[
Mundschenk J, Lehnert H. Treatment of malignant pheochromocytoma. Exp Clin Endocrinol Diabetes 106, 373–376, 1998.
]Search in Google Scholar
[
Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346, 1459–1466, 2002.
]Search in Google Scholar
[
Nomoto Y, Kawano K, Fujisawa N, Yoshida K, Yamashita T, Makita M, Takeshita H, Kamimori K, Yanagi S, Yoshiyama M. Pheochromocytoma multisystem crisis behaving like interstitial pneumonia: An autopsy case. Intern Med 56, 149–152, 2017.
]Search in Google Scholar
[
Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134, 315–329, 2001.
]Search in Google Scholar
[
Roden M. How to detect pheochromocytomas? – The diagnostic relevance of plasma free metanephrines. Wien Klin Wochenschrt 114, 246–251, 2002.
]Search in Google Scholar
[
Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88, 553–558, 2003.
]Search in Google Scholar
[
Schmedtje JF, Jr Sax S, Pool JL, Goldfarb RA, Nelson EB. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med 83, 770–772, 1987.
]Search in Google Scholar
[
Stenstrom G, Waldenstrom J. Positive correlation between urinary excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Results in patients with sustained and paroxysmal hypertension and multiple endocrine neoplasia. Acta Med Scand 217, 73–77, 1985.
]Search in Google Scholar
[
Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 30, 899–908, 2006.
]Search in Google Scholar
